Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:00 PM
Ignite Modification Date:
2025-12-24 @ 2:00 PM
NCT ID:
NCT02042495
Eligibility Criteria:
Inclusion Criteria:
* Have a confirmed diagnosis of endometrial cancer based on an endometrial sampling though biopsy or dilatation and curettage
* Must be able to undergo appropriate surgical staging for endometrial cancer
* Must consent to be in the study and must have signed and dated an IRB-approved consent form conforming to government and institutional guidelines
Exclusion Criteria:
* Patients with a contraindication to receiving metformin treatment
* Patients with cognitive impairment
* Renal or hepatic functioning \> 125% upper limit of normal
* Currently on medications for metabolic diseases, such as diabetes mellitus
* History of lactic acidosis
* Treatment with medications that may increase metformin levels: cationic drugs, e.g., digoxin, amiloride, procainamide, trimethoprim, vancomycin, triamterene, and morphine
* History of chronic alcohol abuse
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT02042495
Study Brief:
Protocol Section:
NCT02042495